Oncology MRI

>

Latest News

New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer

September 12th 2024

Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.

Comparative Study Says Enhanced MRI Offers Optimal Detection of Neuroendocrine Tumor Liver Metastases
Comparative Study Says Enhanced MRI Offers Optimal Detection of Neuroendocrine Tumor Liver Metastases

September 5th 2024

Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals

September 3rd 2024

New Research Highlights Emerging MRI Contrast Agent for Bladder Imaging
New Research Highlights Emerging MRI Contrast Agent for Bladder Imaging

August 21st 2024

Study: Advanced MRI Neuroimaging May Have Changed Treatment for 44 Percent of Patients with High-Grade Gliomas
Study: Advanced MRI Neuroimaging May Have Changed Treatment for 44 Percent of Patients with High-Grade Gliomas

August 15th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.